Abstract
A nationwide neonatal sreening program for phenylketonuria (PKU), maple syrup urine disease (MSUD), homocystinuria, histidinemia and galactosemia was started in Japan in 1977. The total number of infants screened had reached 6,311,754 by March, 1982. A follow-up study revealed the incidence of the disease in Japan: 1/108,823 for PKU; 1/450,840 for hyperphenylalaninemia (HPA); 1/1,577,939 for biopterin deficiency; 1/525,980 for MSUD; 1/1,051,959 for homocystinuria; 1/8,371 for histidinemia, and 1/788,969 for galactosemia type 1. The incidences of PKU, HPA, homocystinuria, and galactosemia (type 1) were found to be markedly low in Japan as compared with those in Caucasian countries. There was no great difference in the incidence of MSUD between both. On the other hand, the incidence of histidinemia was higher in Japan.
It was found that most of the patients with PKU, HPA, MSUD, homocystinuria, or galactosemia are developing normally due to the early initiation of dietary treatment. These results clearly indicate that the neonatal mass screening program plays a great role in preventing the occurrence of handicapped children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beutler E, Balude MC (1966) A simple spot screening test for galactosemia. J Lab Clin Med 68:137–141
Bickel H (1983) Neonatal mass screening for inborn errors of metabolism. Recent Progress in Perinatal Medicine and Prevention of Congenital Anomaly. Medical Information Services, Inc., Tokyo, pp 260–269
Curtius H, Niederwieser A, Viscontini M, Otten A, Schaub J, Scheibenreiter S (1979) Atypical phenylketonuria due to tetrahydrobiopterin deficiency: Diagnosis and treatment with tetrahydrobiopterin, dihydrobiopterin and sepiapterin. Clin Chim Acta 93:251–262
Editorial (1974) Histidinemia. To treat or not to treat? Lancet 1:719
Guthrie R (1968) Screening for inborn error of metabolism in the newborn infant—a multiple test program. Birth Defects 4:92–98
Guthrie R (1972) Mass screening for genetic disease. Hosp Pract 92-100
La Du BN (1979) Histidinemia. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease. McGraw-Hill Book Company, New York, pp 317–327
Narisawa K, Hayakawa H, Arai N, Matsuo N, Tateda T, Naritomi K, Tada K (1983) Diagnosis of variant forms of hyperphenylalaninemia using filter paper spots of urine. J Pediatr 103:577–579
Snyderman SE, Sansaricq C, Norten PM, Manka M (1979) The nutritional therapy of histidinemia. J Pediatr 95:712–715
Tada K, Tateda H, Arishima S, Sakai K, Kitagawa T, Aoki K, Suwa S, Kawamura M, Oura T, Takesada M, Kuroda Y, Yamashita F, Matsuda I, Naruse H (1982) Intellectual development in patients with untreated histidemia. J Pediatr 101:562–563
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tada, K., Tateda, H., Arashima, S. et al. Follow-up study of a nation-wide neonatal metabolic screening program in Japan. Eur J Pediatr 142, 204–207 (1984). https://doi.org/10.1007/BF00442450
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442450